000 01444 a2200409 4500
005 20250515224934.0
264 0 _c20101122
008 201011s 0 0 eng d
022 _a1365-2982
024 7 _a10.1111/j.1365-2982.2010.01520.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcKernan, D P
245 0 0 _aThe probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.
_h[electronic resource]
260 _bNeurogastroenterology and motility
_cSep 2010
300 _a1029-35, e268 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnalysis of Variance
650 0 4 _aAnimals
650 0 4 _aBehavior, Animal
650 0 4 _aBifidobacterium
650 0 4 _aCorticosterone
_xblood
650 0 4 _aDilatation, Pathologic
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aIrritable Bowel Syndrome
_xtherapy
650 0 4 _aPain Management
650 0 4 _aPain Measurement
650 0 4 _aProbiotics
_xtherapeutic use
650 0 4 _aRats
650 0 4 _aRats, Inbred WKY
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aStress, Psychological
700 1 _aFitzgerald, P
700 1 _aDinan, T G
700 1 _aCryan, J F
773 0 _tNeurogastroenterology and motility
_gvol. 22
_gno. 9
_gp. 1029-35, e268
856 4 0 _uhttps://doi.org/10.1111/j.1365-2982.2010.01520.x
_zAvailable from publisher's website
999 _c19870132
_d19870132